Biomedical Sealant Market – Size, Share, Outlook, and Opportunity
Analysis, 2018 – 2026
Biomedical sealants have emerged as a promising product for replacing staples and sutures to
prevent liquid and air leakages after and during surgeries. Surgical sealants are made from synthetic
or natural polymers or a combination of both. Sealant materials are required to be elastic and
compliant with the tissue to allow movement and function of various tissues of lungs, blood vessel,
skin, and heart.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1936
These materials include polyurethane, glycol, and polyethylene glycol or naturally occurring
polysaccharides or proteins. Polyurethane is used in biomedical sealants due to its property of
strong adhesion and high elasticity to tissues. Polyethylene glycol in sealants is widely used as
hemostatic adhesive and fluid barrier.
Synthetic biomedical sealants have higher mechanical strength and tissue bonding properties as
compared to natural biomedical sealants. These physical properties and adhesion strength are some
key factors of implementing biomedical sealants to seal the wound area without causing any
hindrance to the function and movement of tissues. Surgical sealants are used commonly to prevent
leakage of any fluid or air from a surgical incision.
Biomedical Sealant Market Drivers:-